Literature DB >> 8345491

Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension.

M G Buckley1, N D Markandu, M A Miller, G A Sagnella, G A MacGregor.   

Abstract

We have developed a radioimmunoassay for the measurement of immunoreactive BNP (1-32) in human plasma. Simultaneous measurement of ANP have also been carried out to allow for direct comparison between circulating BNP and ANP. Plasma levels of immunoreactive BNP (means +/- SEM) were 1.1 +/- 0.1 pmol/l in 36 normal healthy subjects and were significantly elevated in 50 patients with essential hypertension (1.6 +/- 0.2 pmol/l, P < 0.02). Similarly, in patients with essential hypertension plasma levels of ANP were also significantly raised (5.5 +/- 0.6 pmol/l, P < 0.001) when compared with the group of normal healthy subjects (2.8 +/- 0.2 pmol/l). ANP was significantly higher than BNP in normal subjects and in patients with essential hypertension, with ANP/BNP ratios of 2.8 +/- 0.2 and 3.8 +/- 0.3, respectively, in these two groups. A major finding was a significant and positive association between plasma levels of both BNP and ANP within the healthy subjects (r = 0.49, P < 0.05, n = 36) and within the hypertensive subjects (r = 0.76, P < 0.001, n = 50). When all plasma values for BNP and ANP were taken together for both groups, there was an overall correlation coefficient of 0.65 (P < 0.001, n = 86). Both BNP and ANP had significant positive associations with age in hypertensive patients, with correlation coefficients of 0.53 (P < 0.001, n = 50) and of 0.53 (P < 0.001, n = 50) for BNP and ANP, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8345491

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  14 in total

1.  Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosis.

Authors:  Otto A Sanchez; David R Jacobs; Hossein Bahrami; Carmen A Peralta; Lori B Daniels; João A Lima; Alan Maisel; Daniel A Duprez
Journal:  J Hypertens       Date:  2015-05       Impact factor: 4.844

2.  Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP.

Authors:  S Talwar; A Siebenhofer; B Williams; L Ng
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

3.  Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1.

Authors:  Katherine E Wiley; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

4.  Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care.

Authors:  S J McClure; L Caruana; A P Davie; S Goldthorp; J J McMurray
Journal:  BMJ       Date:  1998-08-22

5.  Association of plasma B-type natriuretic peptide concentrations with longitudinal blood pressure tracking in African Americans: findings from the Jackson Heart Study.

Authors:  Ervin R Fox; Solomon K Musani; Preeti Singh; Aurelian Bidulescu; Harsha S Nagarajarao; Tandaw E Samdarshi; Michael W Steffes; Thomas J Wang; Herman A Taylor; Ramachandran S Vasan
Journal:  Hypertension       Date:  2012-11-26       Impact factor: 10.190

6.  Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome.

Authors:  Yuanyuan Bao; Xiliang Shang; Linuo Zhou; Renming Hu; Yiming Li; Wei Ding
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

Review 7.  NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes.

Authors:  Marcus Vinicius Bolivar Malachias; Magnus Olof Wijkman; Marcello Casaccia Bertoluci
Journal:  Diabetol Metab Syndr       Date:  2022-05-03       Impact factor: 5.395

8.  The heart as an endocrine organ.

Authors:  Tsuneo Ogawa; Adolfo J de Bold
Journal:  Endocr Connect       Date:  2014-04-15       Impact factor: 3.335

9.  The prevalence, characteristics, and clinical significance of abnormal albuminuria in patients with hypertension.

Authors:  Shunsuke Murai; Satoru Tanaka; Yasuaki Dohi; Genjiro Kimura; Nobuyuki Ohte
Journal:  Sci Rep       Date:  2014-01-24       Impact factor: 4.379

10.  Hypertension is associated with preamyloid oligomers in human atrium: a missing link in atrial pathophysiology?

Authors:  Tatiana N Sidorova; Lisa C Mace; K Sam Wells; Liudmila V Yermalitskaya; Pei-Fang Su; Yu Shyr; James B Atkinson; Agnes B Fogo; Joseph K Prinsen; John G Byrne; Michael R Petracek; James P Greelish; Steven J Hoff; Stephen K Ball; Charles G Glabe; Nancy J Brown; Joey V Barnett; Katherine T Murray
Journal:  J Am Heart Assoc       Date:  2014-12-02       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.